GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Enovis ENOV · USD

Health Care · US listing · 🇺🇸 United States

Compare

28.54

+5.08%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$2.25bn

FY2016FY2025

Net income

−$1.18bn

FY2016FY2025

Free cash flow

$19.9m

FY2016FY2025

Shareholders' equity

$1.49bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$2.25bn$2.11bn$1.71bn$1.56bn$1.43bn$3.07bn$3.33bn$2.19bn$3.30bn$3.65bn
Research and development$120.3m$91.3m$75.3m$60.8m$49.1m$34.3m$61.8m$34.2m$42.9m$39.3m
Operating income−$18.9m−$765.8m−$47.4m−$71.2m−$62.8m$162.3m$170.0m$286.0m$29.2m$238.0m
Net income−$1.18bn−$825.5m−$33.3m−$13.3m$71.7m$42.6m−$527.6m$140.2m$151.1m$128.1m
Diluted earnings per share-20.86-14.14-0.61-0.251.130.92-11.263.573.653.11

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$3.83bn$4.72bn$4.51bn$4.27bn$8.52bn$7.35bn$7.39bn$6.60bn$6.72bn$6.39bn
Cash and short-term investments$36.4m$48.2m$36.2m$24.3m$680.3m$101.1m$109.6m$245.0m$411.6m$221.7m
Total liabilities$2.34bn$2.15bn$1.09bn$823.4m$3.85bn$3.76bn$3.90bn$3.13bn$2.99bn$3.29bn
Debt$1.32bn$1.33bn$466.2m$259.3m$2.09bn$2.23bn$2.31bn$1.20bn$1.06bn$1.29bn
Shareholders' equity$1.49bn$2.56bn$3.42bn$3.45bn$4.62bn$3.54bn$3.44bn$3.27bn$3.50bn$2.90bn
Shares outstanding57m58m55m54m64m46m47m39m41m41m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$217.3m$113.5m$135.0m−$55.9m$356.1m$301.9m$130.9m$226.4m$218.8m$247.0m
Capital spending−$197.4m−$180.7m−$122.2m−$105.5m−$104.2m−$114.8m−$125.4m−$69.6m−$68.8m−$63.3m
Free cash flow$19.9m−$67.2m$12.8m−$161.3m$251.9m$187.2m$5.5m$156.7m$150.0m$183.7m
Dividends paid———————−$1.27bn—−$896.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$582.8m$589.2m$575.8m$548.9m$564.5m$558.8m$561.0m$505.2m
Operating income$15.5m$19.8m$48.3m$9.0m−$16.4m−$48.2m−$664.7m$53,000
Net income−$1.2m−$8.8m−$520.6m−$571.1m−$36.7m−$56.0m−$703.3m−$31.5m
Diluted earnings per share-0.02-0.15-9.17-10.06-0.65-0.99-12.05-0.56
Cash from operations$75.0m$23.0m$88.0m$82.0m$47.0m−$1.0m$88.0m$53.0m
Capital spending−$43.0m−$52.0m−$56.0m−$53.0m−$44.0m−$43.0m−$53.0m−$51.0m
Free cash flow$32.0m−$29.0m$32.0m$29.0m$3.0m−$44.0m$35.0m$2.0m
Total assets$3.77bn$3.83bn$3.83bn$4.43bn$5.02bn$4.88bn$4.72bn$5.55bn
Cash and short-term investments$12.6m$33.1m$36.4m$33.6m$44.1m$38.5m$48.2m$35.4m
Debt$1.31bn$1.35bn$1.32bn$1.34bn$1.37bn$1.37bn$1.35bn$1.33bn
Shareholders' equity$1.48bn$1.48bn$1.49bn$2.02bn$2.58bn$2.62bn$2.56bn$3.33bn

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-50.0%-36.3%-2.8%1.4%-6.5%5.3%
Net margin-52.7%-39.2%-1.9%-0.9%5.0%1.4%
Return on equity-79.5%-32.2%-1.0%-0.4%1.6%1.2%
Return on assets-30.9%-17.5%-0.7%-0.3%0.8%0.6%
Free cash flow yield35.0%24.1%22.6%4.4%34.7%43.2%
Revenue growth6.7%23.5%9.2%9.6%-53.6%-7.7%
Earnings growth43.5%2381.9%150.2%-118.5%68.1%-108.1%
Current ratio2.02x2.17x2.43x1.41x2.25x1.68x
Debt to equity0.89x0.53x0.14x0.08x0.46x0.64x
Equity ratio38.8%54.3%75.8%80.7%54.2%48.2%
Interest coverage-32.29x-13.41x-2.40x0.88x-3.18x3.07x
R&D as a share of sales5.4%4.3%4.4%3.9%3.4%1.1%
Buybacks as a share of market value2.7%-6.9%-0.7%14.7%-37.8%1.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.9%-6.0%-5.5%
Operating income-35.8%——
Net income346.7%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-18.0%-11.8%-6.6%0.7%
Net margin-46.1%-27.0%-16.0%-6.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1.3-3.1-92.0-218.370.171.2-5.510.118.719.8
Price to sales0.71.21.81.93.51.00.90.60.80.7

Market value over time

30 Dec 2016 to 3 Nov 2026, in USD

$2.53bn$1.20bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-37%-22%6%-29%18%2%76%-48%6%56%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 3-to-1 reverse split · 5 Apr 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.